Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age

SIMPLE SUMMARY: Immune checkpoint inhibitor (ICI) therapy has changed the management of many cancers endowed with poor prognosis. However, cardiotoxicity, as well as the possible progression of atherosclerosis, have been described. 2-[18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabretta, Raffaella, Staber, Philipp B., Kornauth, Christoph, Lu, Xia, Binder, Patrick, Pichler, Verena, Mitterhauser, Markus, Haug, Alexander, Li, Xiang, Hacker, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615286/
https://www.ncbi.nlm.nih.gov/pubmed/34827199
http://dx.doi.org/10.3390/biology10111206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615286/
https://www.ncbi.nlm.nih.gov/pubmed/34827199
http://dx.doi.org/10.3390/biology10111206

Ejemplares similares